Clinical Trial Update: Gao Bipolar Spectrum Lithium/Quetiapine Study [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating a lithium/quetiapine combination for bipolar disorder was terminated; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Lithium/Quetiapine (combination) (lithium and quetiapine)

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Bipolar Disorder | Phase 4 | Status: TERMINATED | Results posted: 2015-10-30